Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4547 in FGFR amplified tumors
NCT01795768Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Sep 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fexagratinib in gastric cancer (GC), esophageal cancer, breast cancer, squamous cell carcinoma of the lung (LSCC), sponsored by Royal Marsden NHS Foundation Trust. Status: unknown.
02
Drugs
fexagratinib
03
Conditions
gastric cancer (GC)esophageal cancerbreast cancersquamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT01795768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01795768.